NOT KNOWN DETAILS ABOUT DIHYDROCODEINE 30MG PIL

Baseline evaluations of liver laboratory exams are recommended. APTIOM needs to be discontinued in people with jaundice or other evidence of important liver harm.Result of coadministration of the dual CYP3A4 and CYP2C19 inhibitor with fedratinib has not been examined.diazepam will boost the stage or impact of tazemetostat by influencing hepatic/int